Antovic A - Search Results

1

Changes in von Willebrand factor and ADAMTS13 during IVF.

Westerlund E, Antovic A, Hovatta O, Eberg KP, Blombäck M, Wallén H, Henriksson P. Westerlund E, et al. Among authors: antovic a. Blood Coagul Fibrinolysis. 2011 Mar;22(2):127-31. doi: 10.1097/MBC.0b013e32834363ea. Blood Coagul Fibrinolysis. 2011. PMID: 21192251

2

A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work.

He S, Antovic A, Blombäck M. He S, et al. Among authors: antovic a. Thromb Res. 2001 Sep 1;103(5):355-61. doi: 10.1016/s0049-3848(01)00332-2. Thromb Res. 2001. PMID: 11553368

3

The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism.

Antovic A, Blombäck M, Bremme K, He S. Antovic A, et al. Blood Coagul Fibrinolysis. 2002 Apr;13(3):181-6. doi: 10.1097/00001721-200204000-00002. Blood Coagul Fibrinolysis. 2002. PMID: 11943930

4

Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?

Antovic JP, Rafik Hamad R, Antovic A, Blombäck M, Bremme K. Antovic JP, et al. Among authors: antovic a. Thromb Haemost. 2002 Oct;88(4):644-7. Thromb Haemost. 2002. PMID: 12362237

5

Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.

Antovic JP, Antovic A, He S, Tengborn L, Blombäck M. Antovic JP, et al. Among authors: antovic a. Haemophilia. 2002 Nov;8(6):781-6. doi: 10.1046/j.1365-2516.2002.00689.x. Haemophilia. 2002. PMID: 12410647

6

Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications.

Antovic JP, Yngen M, Ostenson CG, Antovic A, Wallen HN, Jorneskög G, Blombäck M. Antovic JP, et al. Among authors: antovic a. Blood Coagul Fibrinolysis. 2003 Sep;14(6):551-6. doi: 10.1097/00001721-200309000-00006. Blood Coagul Fibrinolysis. 2003. PMID: 12960608

7

Increased hemostasis potential persists in women with previous thromboembolism with or without APC resistance.

Antovic A, Blombäck M, Bremme K, Van Rooijen M, He S. Antovic A, et al. J Thromb Haemost. 2003 Dec;1(12):2531-5. doi: 10.1111/j.1538-7836.2003.00451.x. J Thromb Haemost. 2003. PMID: 14675088 Free article.

8

Overall hemostatic potential (OHP) assay-a possible tool for determination of prothrombotic pattern in FXII deficiency.

Antovic JP, Antovic A, Sten-Linder M, Wramsby M, Blombäck M. Antovic JP, et al. Among authors: antovic a. J Thromb Haemost. 2004 Nov;2(11):2058-60. doi: 10.1111/j.1538-7836.2004.00959.x. J Thromb Haemost. 2004. PMID: 15550050 Free article. No abstract available.

9

Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials.

He S, Cao H, Antovic A, Blombäck M. He S, et al. Among authors: antovic a. Blood Coagul Fibrinolysis. 2005 Jan;16(1):61-7. doi: 10.1097/00001721-200501000-00010. Blood Coagul Fibrinolysis. 2005. PMID: 15650548

10

Marked increase of fibrin gel permeability with very low dose ASA treatment.

Antovic A, Perneby C, Ekman GJ, Wallen HN, Hjemdahl P, Blombäck M, He S. Antovic A, et al. Thromb Res. 2005;116(6):509-17. doi: 10.1016/j.thromres.2005.02.007. Thromb Res. 2005. PMID: 16181986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters